Skip to main content

Superoxide and Post-Ischemic Liver Injury: Potential Therapeutic Target for Liver Transplantation

Buy Article:

$63.00 plus tax (Refund Policy)


Cessation of blood flow to the liver is required during liver transplantation and resectional surgery. A growing body of experimental evidence suggests that restoration of blood flow to the ischemic liver initiates hepatocellular injury which may lead, in some cases, to severe liver injury and graft failure. A large number of studies have implicated reactive oxygen species as potential mediators of post-ischemic tissue injury. Recent developments in genetic engineering as well as chemical modeling, have allowed for the production of novel free radical scavengers including mutated forms of superoxide dismutase (SOD) and low molecular weight SOD mimics with extended circulating half-lives and / or significant membrane permeability's. Application of these newly developed free radical scavengers show promising results in animal models of liver I / R and may become powerful tools in the treatment of post-ischemic liver injury that occurs in liver transplantation.

Keywords: inflammation; leukocytes; microvasculature; nadph oxidase; nitric oxide; pro-inflammatory cytokines; reactive oxygen species; transplantation

Document Type: Review Article


Affiliations: Department of Molecular and Cellular Physiology, LSU Health Sciences Center, 1501 Kings Highway, LA 71130, Shreveport.

Publication date: 2003-12-01

More about this publication?
  • Current Medicinal Chemistry covers all the latest and outstanding developments in medicinal chemistry and rational drug design. Each issue contains a series of timely in-depth reviews written by leaders in the field covering a range of the current topics in medicinal chemistry. Current Medicinal Chemistry is an essential journal for every medicinal chemist who wishes to be kept informed and up-to-date with the latest and most important developments.
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more